Mode
Text Size
Log in / Sign up
N/A N=180

Operative and Non-operative Treatment of Traumatic Arthrotomies

Traumatic Arthrotomy

Enrolled (actual)
180
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcome: Primary: Cost of Treatments — 1089; 11,973 USD

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Operatively treated traumatic arthrotomy (Procedure); Non-operatively treated traumatic arthrotomy (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Wake Forest University Health Sciences
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Cost of Treatments
1089; 11,973
PRIMARY
Complications
4; 18
SECONDARY
Comparing 3-Month Change in Veterans RAND 12-Item Health Survey (VR-12) by Treatment Method
49; 48.1; 50.7; 51.8; 36.9; 32.1

Summary

For the last 70 years, orthopaedic dogma has dictated that all injuries that penetrate the joint capsule require formal irrigation and debridement in the operating room to minimize the risk of developing septic complications. The literature supporting this practice is sparse and stems primarily from wartime injuries that may not be generalizable to the smaller, less contaminated arthrotomies seen in the civilian population. Despite the classical teaching of all traumatic arthrotomies requiring irrigation, debridement, and closure in the operating room, numerous surgeons around the country are beginning to treat small traumatic arthrotomies without surgery. The purpose of this study is to evaluate the cost of treatment as well as incidence of adverse events, such as the development of septic arthritis, in patients undergoing operative and non-operative treatment of traumatic arthrotomies.

Eligibility Criteria

Inclusion Criteria

  • Any patient 18 and older with a traumatic arthrotomy (of any major joint) confirmed by saline load test
  • Direct visualization of a capsular rent or intra-articular contents, or air in the joint on CT or radiographs.

a. Major Joints Include: i. Knee ii. Elbow iii. Wrist iv. Shoulder v. Hip vi. Ankle

Exclusion Criteria

  • Patients who will have severe problems with maintaining follow-up
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02841644). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search